Quantcast

Latest Metered-dose inhaler Stories

2010-02-01 07:00:00

REDWOOD CITY, Calif., Feb. 1 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $15 million financing from existing investors Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. The capital was raised through a convertible loan facility that will convert to Pearl equity at the time...

2010-01-26 07:10:00

HORSHAM, Pa., Jan. 26 /PRNewswire/ -- While cold and flu season is always unpredictable, this year is already one of the worst to date with flu outbreaks across the nation stemming from the arrival of the H1N1 virus and another wave of seasonal flu on the horizon. People with asthma or chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe respiratory symptoms if they contract a cold or the flu, and those with asthma account for about one-third of all people...

2010-01-21 07:00:00

SAN DIEGO, Jan. 21 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing. Investors participating include Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners. Concurrent with this financing, Elevation has added to its board of directors Brent Ahrens, General Partner at Canaan,...

2010-01-06 07:00:00

REDWOOD CITY, Calif., Jan. 6 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 2a dose-ranging study of PT001, the company's glycopyrrolate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation. The data showed that PT001 was well tolerated and was comparable in bronchodilator efficacy and safety to the active control drug...

2009-12-17 05:20:00

GAINESVILLE, Fla., Dec. 17 /PRNewswire/ -- Over the last few weeks there has been an increase of the amount of scare language that is used by e cigarette opposition in an attempt to scare the population concerning the electronic cigarette. Many are questioning the tactics of these groups when the evidence clearly shows that the product is indeed a safer alternative to tobacco according to several studies, lab reports and opinions from top medial and harm reduction specialist around the...

2009-11-18 10:58:00

NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Pulmonary Drug Delivery Technologies - A Global Market Perspective http://www.reportlinker.com/p0164238/Pulmonary-Drug-Delivery-Technologies---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease...

2009-11-12 08:00:00

MIDLOTHIAN, Va., Nov. 12 /PRNewswire/ -- Today, PARI Respiratory Equipment launched a newly updated continuing education class, Managing Respiratory Patients Through Efficient Aerosol Delivery, rounding out their free learning program with seven classes for respiratory therapists, nurses, case managers, and pharmacists. The updated class allows participants to self-study online, enabling easier access for caregivers to update their skills and receive necessary credits for maintaining...

2009-10-22 12:19:07

Research to be presented in November at the 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition Researchers have developed an optimized mouthpiece design to aid efficient drug delivery to the lungs by reducing the amount of medication wasted as it passes through the mouthpiece of an aerosol inhaler. With current inhaler designs, only approximately 10 to 20 percent of asthma medications are delivered to the lungs. And, because the lungs provide a direct and...

2009-09-16 07:10:00

VIENNA, Sept. 16 /PRNewswire/ -- Teva Respiratory, a division of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), today announced results from an analysis of the cost-effectiveness of three different inhaled corticosteroids (ICSs) in a "real-life" asthmatic population. The study found QVAR(R) (beclomethasone dipropionate HFA), an ICS that is able to effectively treat both large and small airway inflammation, to be on average more effective than CFC-beclomethasone dipropionate (BDP) and...

2009-08-26 10:16:00

KENILWORTH, N.J., Aug. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older. The company also announced today that the EMEA has validated the MAA for nomegestrol acetate...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related